Eugene R. Bleecker
University of Arizona(US)Mayo Clinic in Arizona(US)Mayo Clinic in Florida(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory and Cough-Related Research, Inhalation and Respiratory Drug Delivery, IL-33, ST2, and ILC Pathways
Most-Cited Works
- → International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma(2013)3,864 cited
- → Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial(2012)2,183 cited
- → Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program(2009)2,105 cited
- → Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial(2016)1,348 cited
- → Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial(2016)1,344 cited
- → The Salmeterol Multicenter Asthma Research Trial